← Back to Search

Cannabinoid

Cannabidiol (CBD) Isolate in water formulation for Metabolism

N/A
Waitlist Available
Research Sponsored by Colorado State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up venous blood will be sampled at standardized intervals over 4-hours: 0, 10, 20, 30, 45, 60, 120, 180, and 240 minutes and will be analyzed to compare circulating cbd concentration.
Awards & highlights

Study Summary

This study is evaluating the pharmacokinetics of different formulations of CBD.

Eligible Conditions
  • Liver Function
  • Metabolism
  • Pharmacokinetics

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~venous blood will be sampled at standardized intervals over 4-hours: 0, 10, 20, 30, 45, 60, 120, 180, and 240 minutes and will be analyzed to compare circulating cbd concentration.
This trial's timeline: 3 weeks for screening, Varies for treatment, and venous blood will be sampled at standardized intervals over 4-hours: 0, 10, 20, 30, 45, 60, 120, 180, and 240 minutes and will be analyzed to compare circulating cbd concentration. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Compare different formulations of CBD Pharmacokinetic Time to Maximum Concentration- (Tmax)
Compare different formulations of CBD Pharmacokinetic amount of time it takes to decrease the circulating concentration to half of its initial value (t1/2).
Compare different formulations of CBD Pharmacokinetic area under the curve an estimate of total exposure to CBD over time (AUC 0-inf).
+23 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Two Visits Including A Test MealExperimental Treatment2 Interventions
Separated by a minimum of 4 days.
Group II: Five Visits Not Involving A Test MealExperimental Treatment5 Interventions
Separated by a minimum of 14 days.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CBD matching Placebo
2021
N/A
~30
Cannabidiol (CBD) Gum Arabic, sorbitol base formulation
2021
N/A
~30
Cannabidiol (CBD) powder formulation
2021
N/A
~30
Cannabidiol (CBD) Oil based tincture formulation
2021
N/A
~30
Cannabidiol (CBD) Gum Arabic, maltodextrin base formulation
2021
N/A
~30
Cannabidiol (CBD) Isolate in water formulation
2021
N/A
~30

Find a Location

Who is running the clinical trial?

Colorado State UniversityLead Sponsor
125 Previous Clinical Trials
38,333 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Interaction Between Cannabidiol, Meal Ingestion, and Liver Function
Christopher Bell 2021. "Interaction Between Cannabidiol, Meal Ingestion, and Liver Function". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04971837.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top